Key Factors in ADC L...
Health - Beauty - Fitness
Transparency Market Research (TMR) has published a new report titled, ‘Transcatheter Embolization and Occlusion Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global transcatheter embolization and occlusion devices market was valued at US$ 2,957.4 Mn in 2018 and is projected to expand at a CAGR of 7.8% from 2019 to 2027. In terms of volume, the transcatheter embolization and occlusion devices were accounted at 72,93,954 units in 2018.
Overview
· Transcatheter embolization is a process of placing synthetic material or medication called embolic agent into blood vessels through a catheter to block blood flow toward a specific area of the body.
· Embolization is a highly effective way to prevent abnormal bleeding and is minimally invasive as compared to open surgery. Additionally, the technology is proving its efficiency in treatment while performing complex surgeries.
· Surge in incidence of cardiovascular diseases, respiratory disorders, and cancer are anticipated to drive demand for transcatheter embolization and occlusion devices during the forecast period.
· North America dominated the global transcatheter embolization and occlusion devices market in 2018 and the trend is anticipated to continue during the forecast period. Highly structured health care industry, increased adoption of minimally invasive surgeries, and introduction of the Affordable Care Act in the U.S. are expected to drive the market in North America.
· Asia Pacific is likely to be a highly lucrative market for transcatheter embolization and occlusion devices and it is expected to expand at a high CAGR during the forecast period
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2242
Comments